Moleculin Biotech, Inc. (MBRX)
NASDAQ: MBRX · Real-Time Price · USD
2.560
+0.020 (0.79%)
At close: Apr 28, 2026, 4:00 PM EDT
2.560
0.00 (0.00%)
Pre-market: Apr 29, 2026, 6:22 AM EDT
Moleculin Biotech Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -33.56 | -26.05 | -29.77 | -29.03 | -15.89 | |
| Depreciation & Amortization | 0.09 | 0.13 | 0.13 | 0.13 | 0.16 | |
| Stock-Based Compensation | 1.66 | 1.73 | 1.98 | 2.28 | 2.37 | |
| Other Operating Activities | 8.52 | 0.1 | 2.45 | -1.24 | -6.63 | |
| Change in Accounts Payable | 1.33 | -0.47 | 0.4 | 0.73 | 0.24 | |
| Change in Other Net Operating Assets | -0.78 | 0.7 | 1.22 | -0.51 | 0.8 | |
| Operating Cash Flow | -22.74 | -23.86 | -23.59 | -27.64 | -18.95 | |
| Capital Expenditures | - | -0.01 | -0.12 | -0.07 | -0.02 | |
| Investing Cash Flow | - | -0.01 | -0.12 | -0.07 | -0.02 | |
| Issuance of Common Stock | 27.29 | 4.66 | 4.17 | - | 74.75 | |
| Repurchase of Common Stock | -0.01 | -0.03 | -0.03 | -0.02 | -0.02 | |
| Financing Cash Flow | 27.28 | 4.64 | 4.14 | -0.02 | 74.72 | |
| Foreign Exchange Rate Adjustments | 0.05 | -0.03 | -0.02 | -0.03 | -0.02 | |
| Net Cash Flow | 4.6 | -19.27 | -19.6 | -27.76 | 55.73 | |
| Free Cash Flow | -22.74 | -23.88 | -23.72 | -27.71 | -18.97 | |
| Free Cash Flow Per Share | -19.19 | -173.36 | -300.10 | -363.22 | -264.69 | |
| Levered Free Cash Flow | -12.26 | -14.36 | -14.6 | -16.09 | -10.17 | |
| Unlevered Free Cash Flow | -12.26 | -14.36 | -14.6 | -16.09 | -10.17 | |
| Change in Working Capital | 0.56 | 0.23 | 1.62 | 0.22 | 1.04 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.